Relay Therapeutics to Announce Second Quarter 2021 Financial Results and Recent Corporate Highlights

Rhea-AI Summary

Relay Therapeutics (Nasdaq: RLAY) announced plans to report its second quarter 2021 financial results on August 12, 2021, after market closure. The company will not hold a teleconference to discuss these results. Relay Therapeutics is a clinical-stage precision medicine firm focused on transforming drug discovery using its innovative Dynamo™ platform, targeting oncology and genetic diseases. The company aims to tackle challenging protein targets through an integration of computational and experimental technologies.

Positive

• Relay Therapeutics is leveraging advanced technologies for drug discovery.
• Focus on targeted oncology and genetic diseases, indicating a strategic market position.

Negative

• None.

CAMBRIDGE, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading edge computational and experimental technologies, plans to report second quarter 2021 financial results after the close of market on Thursday, August 12, 2021. The company will not be conducting a teleconference in conjunction with its financial results press release.

About Relay Therapeutics

Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Relay Therapeutics is the first of a new breed of biotech created at the intersection of disparate technologies. The Company’s Dynamo™ platform integrates an array of leading-edge computational and experimental approaches to effectively drug protein targets that have previously been intractable. The Company’s initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease. For more information, please visit www.relaytx.com or follow us on Twitter.

Contact:
Pete Rahmer
Senior Vice President, Corporate Affairs and Investor Relations
617-322-0715
prahmer@relaytx.com

Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com

FAQ

When will Relay Therapeutics report its second quarter 2021 financial results?

Relay Therapeutics will report its second quarter 2021 financial results on August 12, 2021, after market close.

Will there be a teleconference for Relay Therapeutics' financial results?

No, Relay Therapeutics will not conduct a teleconference in conjunction with its financial results press release.

What is the focus of Relay Therapeutics' drug discovery efforts?

Relay Therapeutics is focused on targeted oncology and genetic diseases using its Dynamo™ platform.